• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Oncology

The Top Line
Podcast

Behind the headlines of ASCO 2026

Fierce’s Darren Incorvaia, Zoey Becker and Angus Liu break down the biggest takeaways from ASCO 2026.
Ayla Ellison , Angus Liu , Zoey Becker , Darren Incorvaia Jun 5, 2026 9:38am
Cancer patient

Pharma urged to adapt support to changing patient populations

May 29, 2026 6:45am
abbvie

AbbVie scores FDA green light for another ImmunoGen asset

May 28, 2026 7:27am
NVS

Novartis charts another 60 layoffs at US corporate outpost

May 4, 2026 11:09am
Daiichi Sankyo

Daiichi Sankyo plots $1.5B consumer health unit sale to Suntory

Apr 15, 2026 3:22pm
concept of growth and then decline
Favicon Fierce Biotech

Biopharma R&D pipeline shrinks for 1st time in 30 years: report

Apr 3, 2026 8:13am
More News

Corcept wins FDA nod for relacorilant in ovarian cancer

Mar 25, 2026 3:00pm

BMS brings Ashley Park aboard campaign honoring oncologists

Mar 18, 2026 11:25am

Gates-backed TerraPower sketches out $450M radioisotope facility

Mar 18, 2026 10:40am

Safety signals prompt Ipsen to withdraw cancer med Tazverik

Mar 9, 2026 10:07am
See more stories

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings